Association of TNF and FcγRΙΙΙA gene polymorphisms with differential response to infliximab in a Greek cohort of Crohn’s disease patients

BACKGROUND AND AIM: Infliximab (IFX) has revolutionized the treatment of patients with Crohn’s disease (CD). However, a significant proportion of patients may fail to respond primarily or lose response over time. The genetic background of a particular individual may partially explain differences in...

Descripción completa

Detalles Bibliográficos
Autores principales: Papamichael, Konstantinos, Gazouli, Maria, Karakoidas, Christos, Panayotou, Ioanna, Roma-Giannikou, Eleftheria, Mantzaris, Gerassimos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959457/
https://www.ncbi.nlm.nih.gov/pubmed/24714240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959457/
https://www.ncbi.nlm.nih.gov/pubmed/24714240

Ejemplares similares